Pushkala Muralitharan

Pushkala Muralitharan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Pushkala Muralitharan's NPI, 1700806304, was assigned on July 20, 2006. Pushkala Muralitharan holds New Hampshire license 10055.

Pushkala Muralitharan's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Pushkala Muralitharan's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Pushkala Muralitharan is also affiliated with Concord Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Pushkala Muralitharan to 1 more hospital, 2 group practices and clinics, 1 home health agency, 1 hospice and 1 medical group, each named with a free account. Pushkala Muralitharan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Pushkala Muralitharan practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Pushkala Muralitharan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Pushkala Muralitharan is licensed in New Hampshire.

CMS data shows 595 Medicare services from Pushkala Muralitharan across 5 procedure codes in 2024, for 258 Medicare patients. Medicare paid $44,597 for them. Every service was in an office.

CMS counts 258 Medicare patients who saw Pushkala Muralitharan in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Pushkala Muralitharan's median patient age at 68, with 68% women.

In 2024, Pushkala Muralitharan wrote 7,726 Medicare Part D claims for 452 patients. 88% of them were for generic drugs. CMS names the drug for 6,833 of them, across 124 drugs with 11 or more claims each, at $451,376 in total drug cost. In 2023, CMS named 7,186 claims across 135 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Pushkala Muralitharan for performance year 2024, reported through an alternative payment model (APM). Pushkala Muralitharan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Pushkala Muralitharan from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $20.